Xia-Qing Li
Overview
Explore the profile of Xia-Qing Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xing X, Li X, Yin S, Ma H, Xiao S, Tulamaiti A, et al.
Theranostics
. 2025 Feb;
15(6):2104-2120.
PMID: 39990208
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a global prevalence and poor prognosis, largely due to immune escape mechanisms. However, the potential reasons for the decreased infiltration...
2.
Zeng Q, Li L, Chang T, Sun Y, Zheng B, Xue L, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2411503.
PMID: 39932442
Targeting oxidative phosphorylation (OXPHOS) through inhibiting the electron transport chain (ETC) has shown promising pre-clinical efficacy in cancer therapy. Although aerobic glycolysis is a hallmark of cancer, emerging evidence suggest...
3.
Tulamaiti A, Xiao S, Yang Y, Mutailifu M, Li X, Yin S, et al.
Transl Oncol
. 2025 Jan;
52():102261.
PMID: 39752908
Metabolic reprogramming is a hallmark of cancer. The"Warburg effect", also known as aerobic glycolysis, is an essential part of metabolic reprogramming and a central contributor to cancer progression. Moreover, hypoxia...
4.
Li X, Xiao Z, Ma K, Liu X, Liu H, Hu B, et al.
Antioxid Redox Signal
. 2024 Nov;
PMID: 39495586
The limited therapeutic options for diabetic tubulopathy (DT) in early diabetic kidney disease (DKD) reflect the difficulty of targeting renal tubular compartment. While renin-angiotensin-aldosterone system (RAS) inhibitors are commonly utilized...
5.
Li X, Yin S, Chen L, Tulamaiti A, Xiao S, Zhang X, et al.
BMC Cancer
. 2024 Jan;
24(1):116.
PMID: 38262966
Background: Pancreatic adenocarcinoma (PDAC) ranks as the fourth leading cause for cancer-related deaths worldwide. N6-methyladenosine (m6A) and long non-coding RNAs (lncRNAs) are closely related with poor prognosis and immunotherapeutic effect...
6.
Li X, Liu J, Liu H, Meng Y
Syst Rev
. 2022 Sep;
11(1):197.
PMID: 36076305
Background: Acute kidney injury (AKI) induced by ischemia/reperfusion injury significantly contribute to the burden of end-stage renal disease. Extracellular vesicles (EVs), especially for stem/progenitor cell-derived EVs (stem/progenitor cell-EVs), have emerged...
7.
Liu H, Li X, Liu J, Cui S, Liu H, Hu B, et al.
Front Med (Lausanne)
. 2021 Sep;
8:725598.
PMID: 34568382
Obesity increases the risk of other diseases, including kidney disease. Local renal tubular renin-angiotensin system (RAS) activation may play a role in obesity-associated kidney disease. Extracellular vehicles (EVs) transmit necessary...
8.
Li X, Liu H, Meng Y, Yin H, Gao W, Yang X, et al.
J Med Virol
. 2021 Jul;
93(12):6641-6652.
PMID: 34314040
Acute kidney injury (AKI) may develop in patients with coronavirus disease 2019 (COVID-19) and is associated with in-hospital death. We investigated the incidence of AKI in 223 hospitalized COVID-19 patients...
9.
Li X, Lerman L, Meng Y
Clin Sci (Lond)
. 2020 Oct;
134(20):2741-2754.
PMID: 33111949
Extracellular vesicles (EVs) are membrane-bound vesicles released by most cells and are found in diverse biological fluids. The release of EVs provides a new mechanism for intercellular communication, allowing cells...
10.
Inhibition of neurite outgrowth using commercial myelin associated glycoprotein-Fc in neuro-2a cells
Liu F, Gao M, Bai J, Wang Y, Li X
Neural Regen Res
. 2018 Sep;
13(11):1893-1899.
PMID: 30233061
Myelin-associated glycoprotein (MAG) inhibits the growth of neurites from nerve cells. Extraction and purification of MAG require complex operations; therefore, we attempted to determine whether commercially available MAG-Fc can replace...